86 related articles for article (PubMed ID: 21269313)
1. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Nitta Y; Ikeya T; Sakakibara A; Tomita Y
J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
[TBL] [Abstract][Full Text] [Related]
2. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
3. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
4. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Kageshita T; Kuribayashi N; Ono T
J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma.
Nin-Asai R; Sawada M; Matsumoto T; Saito S; Yokota K; Akiyama M
J Dermatol; 2014 Feb; 41(2):178-9. PubMed ID: 24387309
[No Abstract] [Full Text] [Related]
7. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
8. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver.
Ueda H; Hamagami H; Tanaka H; Kida Y; Ichinose M
Oncol Rep; 2005 Dec; 14(6):1543-6. PubMed ID: 16273253
[TBL] [Abstract][Full Text] [Related]
9. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
10. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
[TBL] [Abstract][Full Text] [Related]
11. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
[TBL] [Abstract][Full Text] [Related]
12. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
[TBL] [Abstract][Full Text] [Related]
13. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Maeda K; Miura S; Kawamura M; Jimbow K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
[TBL] [Abstract][Full Text] [Related]
14. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
[No Abstract] [Full Text] [Related]
15. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of malignant melanoma].
Ishihara K; Ikegawa S
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493
[TBL] [Abstract][Full Text] [Related]
17. Paralytic ileus associated with a combination of dacarbazine-nimustine hydrochloride-vincristine chemotherapy.
Takata Y; Hayashi S; Ohno T; Dekio S
J Dermatol; 1997 Oct; 24(10):682-3. PubMed ID: 9375471
[No Abstract] [Full Text] [Related]
18. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
19. High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Corti C; Theodore C; Bayle C; Rougier P; Nasr F; Cosset JM; Girinsky T; Hayat M; Ribrag V
Hematol Oncol; 1996 Dec; 14(4):159-63. PubMed ID: 9267461
[TBL] [Abstract][Full Text] [Related]
20. [Malignant melanoma of the alimentary tract].
Nakamura T; Ide H
Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
